Hydrochloric Acid

Hydrochloric Acid

SCHEMBL3592047

CCCCN(CCCC)[P+](N(CCCC)CCCC)(N(CCCC)CCCC)N(CCCC)CCCC.[Cl-]

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CA12 O43570 4/20 0.39
CA1 P00915 4/20 0.39
CA9 Q16790 4/20 0.39
ALDH1A1 P00352 1/20 0.39
ALDH2 P05091 1/20 0.39
CA2 P00918 2/20 0.36
MMP1 P03956 1/20 0.36
MMP2 P08253 1/20 0.36
MMP3 P08254 1/20 0.36
MMP8 P22894 1/20 0.36
TSHR P16473 3/20 0.35
LMNA P02545 1/20 0.35
DNM1 Q05193 3/20 0.35
THRB P10828 1/20 0.33
PLA2G1B P04054 1/20 0.30
PLA2G2A P14555 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL6151479 0.94 CA12 (0.39) CA12CA1CA9ALDH1A1ALDH2
Iodide SCHEMBL6151762 0.94 CA12 (0.39) CA12CA1CA9ALDH1A1ALDH2
Hydrochloric Acid SCHEMBL6150730 0.88 DNM1 (0.50) CA12CA1CA9CA2TSHR
Bromide SCHEMBL6731553 0.86 CA12 (0.37) CA12CA1CA9ALDH1A1ALDH2
Iodide SCHEMBL4346703 0.86 CA12 (0.37) CA12CA1CA9ALDH1A1ALDH2
Iodide SCHEMBL6151091 0.86 CA12 (0.37) CA12CA1CA9ALDH1A1ALDH2
Hydrochloric Acid SCHEMBL3606950 0.86 DNM1 (0.36) CA12CA1CA9ALDH1A1ALDH2
Bromide SCHEMBL3605614 0.84 DNM1 (0.35) CA12CA1CA9ALDH1A1ALDH2
Bromide SCHEMBL6151303 0.82 DNM1 (0.50) CA12CA1CA9ALDH1A1CA2
Bromide SCHEMBL6150481 0.82 DNM1 (0.50) CA12CA1CA9ALDH1A1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7714144-B2 5-chloro-1,3-dimethyl-1H-pyrazole-4-carbonyl chloride are initially charged in polyethylene glycol dimethyl ether, potassium fluoride and tetraphenylphosphonium bromide as phase tranfer catalyst and sulfolane to produce 5-fluoro-1,3-dimethyl-1H-pyrazole-4-carbonyl fluoride BAYER CROPSCIENCE AG (DE) 2010-05-11 US claimed
US-20090306401-A1 Method For The Production of 5-Fluoro-1,3-Dialkyl-1H-Pyrazol-4-Carbonyl Fluorides BAYER CROPSCIENCE AG (DE) 2009-12-10 US claimed
EP-1928839-B1 METHOD FOR THE PRODUCTION OF 5-FLUORO-1,3-DIALKYL-1H-PYRAZOL-4-CARBONYL FLUORIDES BAYER CROPSCIENCE AG (DE) 2008-12-31 EP claimed
EP-0958052-B1 AMIDOPHOSPHONIUM-SALT-CONTAINING CATALYST FOR HALOGEN-FLUORINE EXCHANGE REACTIONS CLARIANT GMBH (DE) 2002-12-04 EP claimed
JP-2001508359-A 2001-06-26 JP claimed
US-6103659-A Catalyst comprising an amidophosphonium salt for halex reactions AVENTIS RESEARCH & TECHNOLOGIES GMBH & CO. KG (DE) 2000-08-15 US claimed
EP-0958052-A1 AMIDOPHOSPHONIUM-SALT-CONTAINING CATALYST FOR HALOGEN-FLUORINE EXCHANGE REACTIONS Aventis Research & Technologies GmbH & Co. KG (DE) 1999-11-24 EP claimed
WO-1998032532-A1 AMIDOPHOSPHONIUM-SALT-CONTAINING CATALYST FOR HALOGEN-FLUORINE EXCHANGE REACTIONS AVENTIS RESEARCH & TECHNOLOGIES GMBH & CO KG (DE) 1998-07-30 WO claimed
US-7714144-B2 5-chloro-1,3-dimethyl-1H-pyrazole-4-carbonyl chloride are initially charged in polyethylene glycol dimethyl ether, potassium fluoride and tetraphenylphosphonium bromide as phase tranfer catalyst and sulfolane to produce 5-fluoro-1,3-dimethyl-1H-pyrazole-4-carbonyl fluoride BAYER CROPSCIENCE AG (DE) 2010-05-11 US disclosed
US-20090306401-A1 Method For The Production of 5-Fluoro-1,3-Dialkyl-1H-Pyrazol-4-Carbonyl Fluorides BAYER CROPSCIENCE AG (DE) 2009-12-10 US disclosed
EP-1928839-B1 METHOD FOR THE PRODUCTION OF 5-FLUORO-1,3-DIALKYL-1H-PYRAZOL-4-CARBONYL FLUORIDES BAYER CROPSCIENCE AG (DE) 2008-12-31 EP disclosed
EP-0944564-B9 HALOGEN EXCHANGE REACTIONS AND USES THEREOF ALBEMARLE CORP (US) 2005-01-19 EP disclosed
EP-1054853-B1 CATALYST RECOVERY FOR HALOGEN EXCHANGE REACTIONS ALBEMARLE CORP (US) 2003-03-19 EP disclosed
EP-0958052-B1 AMIDOPHOSPHONIUM-SALT-CONTAINING CATALYST FOR HALOGEN-FLUORINE EXCHANGE REACTIONS CLARIANT GMBH (DE) 2002-12-04 EP disclosed
EP-0923508-A2 PROCESS FOR PREPARING FLUORINE-CONTAINING COMPOUNDS Aventis Research & Technologies GmbH & Co. KG (DE) 1999-06-23 EP disclosed
EP-0908443-A2 Process for the preparation of fluorinated aromatic compounds Clariant GmbH (DE) 1999-04-14 EP disclosed
WO-1999011588-A1 METHOD FOR PRODUCING COMPOUNDS CONTAINING FLUORINE, IN PARTICULAR FLUOROBENZALDHYDES AND FLUOROBENZONITRILES AVENTIS RESEARCH & TECHNOLOGIES GMBH & CO. KG (DE) 1999-03-11 WO disclosed
EP-0878461-A2 Process for the preparation of 3,5-difluoroaniline Clariant GmbH (DE) 1998-11-18 EP disclosed
WO-1998032532-A1 AMIDOPHOSPHONIUM-SALT-CONTAINING CATALYST FOR HALOGEN-FLUORINE EXCHANGE REACTIONS AVENTIS RESEARCH & TECHNOLOGIES GMBH & CO KG (DE) 1998-07-30 WO disclosed
WO-1998005610-A2 PROCESS FOR PREPARING FLUORINE-CONTAINING COMPOUNDS AVENTIS RESEARCH & TECHNOLOGIES GMBH & CO KG (DE) 1998-02-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090306401-A1 Method For The Production of 5-Fluoro-1,3-Dialkyl-1H-Pyrazol-4-Carbonyl Fluorides CYP4X1, DHX35, AOX1 CA12 2159/4885CA1 1030/4885CA9 632/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.